Endothelial Microparticle Formation by Angiotensin II Is Mediated via Ang II Receptor Type I/NADPH Oxidase/ Rho Kinase Pathways Targeted to Lipid Rafts
- 1 August 2011
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 31 (8), 1898-1907
- https://doi.org/10.1161/atvbaha.110.222703
Abstract
Objective—: Circulating microparticles are increased in cardiovascular disease and may themselves promote oxidative stress and inflammation. Molecular mechanisms underlying their formation and signaling are unclear. We investigated the role of reactive oxygen species (ROS), Rho kinase, and lipid rafts in microparticle formation and examined their functional significance in endothelial cells (ECs). Methods and Results—: Microparticle formation from angiotensin II (Ang II)–stimulated ECs and apolipoprotein E −/− mice was assessed by annexin V or by CD144 staining and electron microscopy. Ang II promoted microparticle formation and increased EC generation and Rho kinase activity. Ang II–stimulated effects were inhibited by irbesartan (Ang II receptor type I blocker) and fasudil (Rho kinase inhibitor). Methyl-β-cyclodextrin and nystatin, which disrupt lipid rafts/caveolae, blocked microparticle release. Functional responses, assessed in microparticle-stimulated ECs, revealed increased production, enhanced vascular cell adhesion molecule/platelet-EC adhesion molecule expression, and augmented macrophage adhesion. Inhibition of epidermal growth factor receptor blocked the prooxidative and proinflammatory effects of microparticles. In vitro observations were confirmed in apolipoprotein E −/− mice, which displayed vascular inflammation and high levels of circulating endothelial microparticles, effects that were reduced by apocynin. Conclusion—: We demonstrated direct actions of Ang II on endothelial microparticle release, mediated through NADPH oxidase, ROS, and Rho kinase targeted to lipid rafts. Microparticles themselves stimulated endothelial ROS formation and inflammatory responses. Our findings suggest a feedforward system whereby Ang II promotes EC injury through its own endothelial-derived microparticles.Keywords
This publication has 56 references indexed in Scilit:
- The reciprocal relationship between adiponectin and LOX-1 in the regulation of endothelial dysfunction in ApoE knockout miceAmerican Journal of Physiology-Heart and Circulatory Physiology, 2010
- NADPH oxidase and lipid raft-associated redox signaling are required for PCB153-induced upregulation of cell adhesion molecules in human brain endothelial cellsToxicology and Applied Pharmacology, 2009
- Proteomics Characterization of Cell Membrane Blebs in Human Retinal Pigment Epithelium CellsMolecular & Cellular Proteomics, 2009
- Differential stimulation of monocytic cells results in distinct populations of microparticlesJournal of Thrombosis and Haemostasis, 2009
- Apocynin, NADPH Oxidase, and Vascular CellsHypertension, 2008
- Apocynin Is Not an Inhibitor of Vascular NADPH Oxidases but an AntioxidantHypertension, 2008
- Circulating MicroparticlesHypertension, 2006
- The phospholipid composition and cholesterol content of platelet-derived microparticles: a comparison with platelet membrane fractionsJournal of Thrombosis and Haemostasis, 2005
- Trafficking of Nuclear Heparin-Binding Epidermal Growth Factor–like Growth Factor into an Epidermal Growth Factor Receptor–Dependent Autocrine Loop in Response to Oxidative StressCancer Research, 2005
- Aldosterone Activates Vascular p38MAP Kinase and NADPH Oxidase Via c-SrcHypertension, 2005